Bell Potter names the best ASX 200 shares to buy in FY26

The broker has good things to say about these shares.

| More on:
A group of businesspeople clapping.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With the new financial year just days away, now could be an opportune time to think about making some new additions to your investment portfolio.

To help you narrow down your options, let's take a look at three ASX 200 shares that Bell Potter has named among its top picks for FY 2026. They are as follows:

JB Hi-Fi Ltd (ASX: JBH)

Bell Potter thinks that retail giant JB Hi-Fi could be an ASX 200 share to buy in the new financial year.

It likes the company due to its estimated 27% market share and its position as Australia's leading technology destination.

The broker believes the latter leaves its well-placed to benefit from an AI driven upgrade cycle. It advised:

We view the retailer as being able to support a higher multiple as we see a sizable upside from the AI driven upgrade cycle/replacement cycle of devices purchased during COVID-peak and given the similarities of JBH and other low gross margin yet high-earnings quality retailers globally.

Bell Potter has a buy rating and $114.00 price target on its shares.

Telix Pharmaceuticals Ltd (ASX: TLX)

Another ASX 200 share to be given the thumbs up by the broker is radiopharmaceuticals leader Telix.

It highlights that its lead product, Illuccix, continues to deliver increasing revenues as the market for PSMA PET expands and as it takes share in its key market in the United States.

Commenting on its positive view of the stock, the broker adds:

We expect average selling price will largely be preserved as the company switches most of its Medicare outpatient client base to the recently approved Gozellix format from 1 October 2025 when the refresh on the pass through pricing is expected to come to bear. Elsewhere, we anticipate the approval of Zircaix in 3Q25 for the imaging of clear cell renal cell carcinoma (ccRCC). Additional short term catalysts include interim data from the PROSTACT Global trial regarding safety and dosimetry from the 30 patient run in study.

Bell Potter has a buy rating and $34.00 price target on Telix's shares.

WiseTech Global Ltd (ASX: WTC)

Finally, this leading provider of software solutions to the global logistics services industry could be an ASX 200 share to buy in FY 2026 according to the broker.

It notes that its shares have pulled back recently due to corporate governance issues around the behaviour of founder Richard White and delays to new product launches. However, it feels the dark clouds are clearing and it will be onwards and upwards for WiseTech Global. It explains:

In our view, however, both issues will progressively fade into the background as a new board and management team are established and CTO is released in FY26. There is also a boost to revenue and earnings to come from a recently announced acquisition – e2Open – and this neatly fills any gap from the delay in launch of new products. Lastly, the stock has underperformed peers like Technology One (TNE) and Xero (XRO) and we now expect relative outperformance as the issues subside.

Bell Potter has a buy rating and $122.50 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Technology One, WiseTech Global, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One, Telix Pharmaceuticals, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Jb Hi-Fi, Technology One, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman looks quizzical as she looks at a graph of the share market.
Broker Notes

Looking for double-digit returns? Check out RBC Capital Markets' picks ahead of reporting season

These shares could deliver strong upside.

Read more »

Man controlling a drone in the sky.
Broker Notes

ASX defence stocks to target according to Bell Potter

The bull run might not be finished yet for these two companies.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

What is Morgans saying about ARB and BHP shares?

Is now the time to buy these popular shares? Let's find out.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 63% since June, why this ASX All Ords share is tipped to keep outperforming in 2026

A leading broker expects more outsized gains for this ASX All Ords share.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A colourfully dressed young skydiver wearing heavy gold gloves smiles and gives a thumbs up as he falls through the sky.
Broker Notes

Bell Potter says this ASX silver stock has 'a sky full of upside'

This exciting stock could be a high risk, high reward pick according to the broker.

Read more »